Dr. Packiam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
195 Little Albany Street
New Brunswick, NJ 08903Phone+1 732-235-2465- Is this information wrong?
Summary
- Vignesh Packiam, MD received his medical degree from the University of Pittsburgh, followed by residency at the University of Chicago, and a two-year Society of Urologic Oncology accredited fellowship at Mayo Clinic. Dr. Packiam treats genitourinary malignancies including bladder, prostate, kidney, and testicular cancer, and is experienced in open and robotic surgery. He has a background in clinical trials and feels it is important to educate his patients about all available options. He has a clinical interest in bladder cancer and supports patient centered groups such as the Bladder Cancer Advocacy Network. He is an active member of numerous cancer societies, serves as a reviewer for multiple urology journals, and has authored over 100 peer-reviewed articles and book chapters.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Minimally Invasive Urologic Surgery, 2018 - 2020
- University of ChicagoResidency, Urology, 2012 - 2018
- University of Pittsburgh School of MedicineClass of 2012
- University of Wisconsin-MadisonB.S., Biology, Philosophy, Dean's Scholar, 2004 - 2008
Certifications & Licensure
- IA State Medical License 2020 - 2025
- NJ State Medical License 2023 - 2025
- MN State Medical License 2018 - 2021
- WI State Medical License 2018 - 2021
- IL State Medical License 2013 - 2020
- American Board of Urology Urology
Publications & Presentations
PubMed
- Sequential endoluminal gemcitabine and docetaxel vs. Bacillus Calmette-Guérin for the treatment of upper tract carcinoma in situ.Ian M McElree, Sarah L Mott, Helen Y Hougen, Michael A O'Donnell, Vignesh T Packiam, Ryan L Steinberg> ;Urologic Oncology. 2024 Apr 11
- Management of Renal Cell Carcinoma With Supradiaphragmatic Inferior Vena Cava Thrombus Diagnosed During Acute COVID-19 Infection.Michael Leyderman, Ian M McElree, Kenneth G Nepple, Yousef Zakharia, Saum Ghodoussipour, Vignesh T Packiam> ;Cureus. 2024 Mar 1
- 1 citationsCombination intravesical chemotherapy for non-muscle invasive bladder cancer (NMIBC) as first-line or rescue therapy: where do we stand now?Mohamad Abou Chakra, Vignesh T Packiam, Igor Duquesne, Michael Peyromaure, Ian M McElree, Michael A O'Donnell> ;Expert Opinion on Pharmacotherapy. 2024 Feb 1
- Join now to see all
Press Mentions
- Gemcitabine-Docetaxel Effective Alternative to BCG in NMIBCMarch 7th, 2023
- Combination Chemotherapy May Be Safe and Effective Alternative for the Treatment of Patients with Non–Muscle-Invasive Bladder Cancer Amid BCG ShortageMarch 1st, 2023
- Given the Lack of Standard BCG Treatments Worldwide, an Alternative Bladder Cancer Treatment Is EvolvingFebruary 28th, 2023
- Join now to see all
Hospital Affiliations
- University of Iowa Hospitals and ClinicsIowa City, Iowa
External Links
- Websitehttps://www.cinj.org/vignesh-t-packiam-md
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: